We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021 AM1)
Updated: 1/4/2013
A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 in Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 1/4/2013
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021 AM1)
Updated: 1/4/2013
A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 in Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 1/4/2013
Click here to add this to my saved trials
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021 AM1)
Updated: 1/4/2013
A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 in Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 1/4/2013
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021 AM1)
Updated: 1/4/2013
A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 in Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 1/4/2013
Click here to add this to my saved trials
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021 AM1)
Updated: 1/4/2013
A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 in Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 1/4/2013
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021 AM1)
Updated: 1/4/2013
A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 in Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 1/4/2013
Click here to add this to my saved trials
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021 AM1)
Updated: 1/4/2013
A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 in Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 1/4/2013
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021 AM1)
Updated: 1/4/2013
A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 in Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 1/4/2013
Click here to add this to my saved trials
Policy on Optimal Epilepsy Management
Updated: 1/4/2013
Policy on Optimized Epilepsy Management: The Use of an Online Social Media Platform to Collect Patient-Entered Data in the Veteran Population
Status: Enrolling
Updated: 1/4/2013
Policy on Optimal Epilepsy Management
Updated: 1/4/2013
Policy on Optimized Epilepsy Management: The Use of an Online Social Media Platform to Collect Patient-Entered Data in the Veteran Population
Status: Enrolling
Updated: 1/4/2013
Click here to add this to my saved trials
Feasibility of the Radio-Frequency Microstimulator System to Improve Arm Function Following Traumatic Brain Injury
Updated: 1/7/2013
A Feasibility Study to Assess the Safety and Efficacy of the Radio-Frequency Microstimulator System to Improve Function of the Arm Following Traumatic Brain Injury
Status: Enrolling
Updated: 1/7/2013
Feasibility of the Radio-Frequency Microstimulator System to Improve Arm Function Following Traumatic Brain Injury
Updated: 1/7/2013
A Feasibility Study to Assess the Safety and Efficacy of the Radio-Frequency Microstimulator System to Improve Function of the Arm Following Traumatic Brain Injury
Status: Enrolling
Updated: 1/7/2013
Click here to add this to my saved trials
A Comparative Study of Global 12 Lead Electroencephalogram to Frontal SedlineTM Electroencephalogram
Updated: 1/8/2013
A Comparative Study of Global 12 Lead Electroencephalogram to Frontal SedlineTM Electroencephalogram Monitoring for the Evaluation of Intraoperative Burst Suppression During Elective Craniotomy or Transphenoidal Pituitary Resection
Status: Enrolling
Updated: 1/8/2013
A Comparative Study of Global 12 Lead Electroencephalogram to Frontal SedlineTM Electroencephalogram
Updated: 1/8/2013
A Comparative Study of Global 12 Lead Electroencephalogram to Frontal SedlineTM Electroencephalogram Monitoring for the Evaluation of Intraoperative Burst Suppression During Elective Craniotomy or Transphenoidal Pituitary Resection
Status: Enrolling
Updated: 1/8/2013
Click here to add this to my saved trials
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
Updated: 1/15/2013
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
A Study of AC105 in Patients With Acute Traumatic Spinal Cord Injury
Updated: 1/16/2013
A Phase 2 Double-blind, Randomized, Placebo-controlled Study to Determine the Safety, Tolerability and Potential Activity of AC105 Following a Regimen of 6 Doses Over 30 Hours in Patients With Acute Traumatic Spinal Cord Injury (SCI) as Compared to Patients Treated With Placebo.
Status: Enrolling
Updated: 1/16/2013
A Study of AC105 in Patients With Acute Traumatic Spinal Cord Injury
Updated: 1/16/2013
A Phase 2 Double-blind, Randomized, Placebo-controlled Study to Determine the Safety, Tolerability and Potential Activity of AC105 Following a Regimen of 6 Doses Over 30 Hours in Patients With Acute Traumatic Spinal Cord Injury (SCI) as Compared to Patients Treated With Placebo.
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
A Study of AC105 in Patients With Acute Traumatic Spinal Cord Injury
Updated: 1/16/2013
A Phase 2 Double-blind, Randomized, Placebo-controlled Study to Determine the Safety, Tolerability and Potential Activity of AC105 Following a Regimen of 6 Doses Over 30 Hours in Patients With Acute Traumatic Spinal Cord Injury (SCI) as Compared to Patients Treated With Placebo.
Status: Enrolling
Updated: 1/16/2013
A Study of AC105 in Patients With Acute Traumatic Spinal Cord Injury
Updated: 1/16/2013
A Phase 2 Double-blind, Randomized, Placebo-controlled Study to Determine the Safety, Tolerability and Potential Activity of AC105 Following a Regimen of 6 Doses Over 30 Hours in Patients With Acute Traumatic Spinal Cord Injury (SCI) as Compared to Patients Treated With Placebo.
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Updated: 1/16/2013
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
Randomized Controlled Trial of the P.L.A.Y. (Play and Language for Autistic Youngsters) Project Intervention for Autism
Updated: 1/16/2013
Randomized Controlled Trial of the P.L.A.Y. Project Intervention for Autism
Status: Enrolling
Updated: 1/16/2013
Randomized Controlled Trial of the P.L.A.Y. (Play and Language for Autistic Youngsters) Project Intervention for Autism
Updated: 1/16/2013
Randomized Controlled Trial of the P.L.A.Y. Project Intervention for Autism
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
Optical Coherence Tomography in Multiple Sclerosis Patients
Updated: 1/19/2013
Optical Coherence Tomography in Multiple Sclerosis Patients
Status: Enrolling
Updated: 1/19/2013
Optical Coherence Tomography in Multiple Sclerosis Patients
Updated: 1/19/2013
Optical Coherence Tomography in Multiple Sclerosis Patients
Status: Enrolling
Updated: 1/19/2013
Click here to add this to my saved trials
Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting
Updated: 1/22/2013
A Randomized, Double-Blind Study of the Time Course of Response to Biphentin Methylphenidate Hydrochloride ER Capsules Compared to Placebo in Children 6 to 12 Years With Attention Deficit Hyperactivity Disorder in Analog Classroom Setting
Status: Enrolling
Updated: 1/22/2013
Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting
Updated: 1/22/2013
A Randomized, Double-Blind Study of the Time Course of Response to Biphentin Methylphenidate Hydrochloride ER Capsules Compared to Placebo in Children 6 to 12 Years With Attention Deficit Hyperactivity Disorder in Analog Classroom Setting
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Dystonia Synergistic Intervention
Updated: 1/22/2013
Determining the Efficacy of Synergistic Intervention With rTMS and Sensorimotor Retraining
Status: Enrolling
Updated: 1/22/2013
Dystonia Synergistic Intervention
Updated: 1/22/2013
Determining the Efficacy of Synergistic Intervention With rTMS and Sensorimotor Retraining
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Dystonia Synergistic Intervention
Updated: 1/22/2013
Determining the Efficacy of Synergistic Intervention With rTMS and Sensorimotor Retraining
Status: Enrolling
Updated: 1/22/2013
Dystonia Synergistic Intervention
Updated: 1/22/2013
Determining the Efficacy of Synergistic Intervention With rTMS and Sensorimotor Retraining
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)
Updated: 1/29/2013
A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects With Moderate to Severe Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 1/29/2013
Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)
Updated: 1/29/2013
A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects With Moderate to Severe Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 1/29/2013
Click here to add this to my saved trials